AbbVie, Roche combo treatment meets main goal of leukemia trial

AbbVie Inc and Roche Holding AG said on Wednesday their immunotherapy delayed the progression of a type of blood and bone marrow cancer when used in combination with the Swiss drugmaker's cancer drug in a late-stage trial.


from Reuters: Health News https://ift.tt/2ADJhvU

Comentarii

Postări populare de pe acest blog

Telehealth hubs offer care options for people living on the edge the virtual world

Overuse on cattle feedlots is a key factor in antibiotic resistance, report says

Bringing Your Ballpark Food Favorites Home